Three carcinoma cell lines, HepG2, SK-BR-3 (HER2 overexpressing), and MCF7, were used to characterize near-infrared (NIR)-emitting QDs and determine their in-vitro toxicity (HER2 underexpressing). The gene discussed is ERBB2; the disease is carcinoma.